Effect of ketotifen on the production of reactive oxygen species from human eosinophils primed by eotaxin

Pharmacology

Volumn 69, Issue 3, 2003, Pages 138-141

  Yamada, Yoshiyuki ^a   Sannohe, Satoshi ^a   Saito, Norihiro ^a   Cui, Chang Hao ^a   Ueki, Shigeharu ^a   Oyamada, Hajime ^a   Kanda, Akira ^a   Yamaguchi, Kazutoshi ^a   Hamada, Kazuyuki ^a   Adachi, Tetsuya ^a   Kayaba, Hiroyuki ^a   Chihara, Junichi ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antihistamine; Eosinophils; Eotaxin; Ketotifen; Reactive oxygen species

Indexed keywords

ANTIALLERGIC AGENT; CALCIMYCIN; EOTAXIN; KETOTIFEN; REACTIVE OXYGEN METABOLITE;

AEROBIC METABOLISM; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANTI-ALLERGIC AGENTS; CALCIMYCIN; CHEMOKINES, CC; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; HUMANS; IONOPHORES; KETOTIFEN; REACTIVE OXYGEN SPECIES;

EID: 10744223016     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072666     Document Type: Article

References (22)

1. Gleich GJ: Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-663.
2. Henricks PA, Nijkamp FP: Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther 2001;14:409-420.
3. Gutierrez-Ramos JC, Lloyd C, Gonzalo JA: Eotaxin: From an eosinophilic chemokine to a major regulator of allergic reactions. Immunol Today 1999;20:500-504.
4. Cui CH, Adachi T, Oyamada H, Kamada Y, Kuwasaki T, Yamada Y, Saito N, Kayaba H, Chihara J: The role of mitogen-activated protein kinases in eotaxin-induced cytokine production from bronchial epithelial cells. Am J Respir Cell Mol Biol 2002;27:329-335.
5. Chihara J, Yamada H, Yamamoto T, Kurachi D, Hayashi-Kameda N, Honda K, Kayaba H, Urayama O: Priming effect of RANTES on eosinophil oxidative metabolism. Allergy 1998;53:1178-1182.
6. Honda K, Chihara J: Eosinophil activation by eotaxin - Eotaxin primes the production of reactive oxygen species from eosinophils. Allergy 1999;54:1262-1269.
7. Paquette D, Rothe MJ: Unapproved dermatologic indications for H2 receptor antagonists, cromolyn sodium, and ketotifen. Clin Dermatol 2000;18:103-111.
8. Hoshino M, Nakamura Y, Shin Z, Fukushima Y: Effects of ketotifen on symptoms and on bronchial mucosa in patients with atopic asthma. Allergy 1997;52:814-820.
9. Nabe M, Miyagawa H, Agrawal DK, Sugiyama H, Townley RG: The effect of ketotifen on eosinophils as measured at LTC4 release and by chemotaxis. Allergy Proc 1991;12:267-271.
10. Kita H, Horie S, Okubo Y, Weiler D, Gleich GJ: Pharmacologic modulation of eosinophil degranulation. J Allergy Clin Immunol 1993;91:332.
11. Hossain M, Okubo Y, Sekiguchi M: Effects of various drugs (staurosporine, herbimycin A, ketotifen, theophylline, FK506 and cyclosporine A) on eosinophil viability. Arerugi 1994;43:711-717.
12. Kishimoto T, Sato T, Ono T, Takahashi K, Kimura I: Effect of ketotifen on the reactivity of eosinophils with the incubation of anti-IgG. Br J Clin Pract 1990;44:226-230.
13. Sannohe S, Adachi T, Hamada K, Honda K, Yamada Y, Saito N, Cui CH, Kayaba H, Ishikawa K, Chihara J: Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis. Eur Respir J 2003;21:925-931.
14. Chanez P, Dent G, Yukawa T, Barnes PJ, Chung KF: Generation of oxygen free radicals from blood eosinophils from asthma patients after stimulation with PAF or phorbol ester. Eur Respir J 1990;3:1002-1007.
15. Chihara J, Kurachi D, Yamamoto T, Yamada H, Wada T, Yasukawa A, Nakajima S: A comparative study of eosinophil isolation by different procedures of CD16-negative depletion. Allergy 1995;50:11-14.
16. Woschnagg C, Garcia R, Rak S, Venge P: IL-5 priming of the PMA-induced oxidative metabolism of human eosinophils from allergic and normal subjects during a pollen season. Clin Exp Allergy 2001;31:555-564.
17. Dobashi K, Iizuka K, Houjou S, Sakai H, Watanabe K, Mori M, Nakazawa T: Effect of cetirizine on antigen-induced tracheal contraction of passively sensitized guinea pigs. Ann Allergy Asthma Immunol 1996;77:310-318.
18. Hoshiko K, Chapman ID, Morley J: Histamine(H1) antagonists and airway hyperreactivity in the guinea pig. Agents Actions Suppl 1991;34:323-333.
19. Ezeamuzie CI, Al-Hage M: Effects of some anti-asthma drugs on human eosinophil super-oxide anions release and degranulation. Int Arch Allergy Immunol 1998,115:162-168.
20. Ezeamuzie CI, Philips E: Histamine H(2) receptors mediate the inhibitory effect of histamine on human eosinophil degranulation. Br J Pharmacol 2000;131:482-488.
21. Elsner J, Braam U, Kimmig D, Zwadlo-Klarwasser G, Kapp A, Schmutzler W: Histamine content of human eosinophil granulocytes. Inflamm Res 1999;48(suppl 1):S19-S20.
22. Adachi T, Vita R, Sannohe S, Stafford S, Alam R, Kayaba H, Chihara J: The functional role of rho and rho-associated coiled-coil forming protein kinase in eotaxin signaling of eosinophils. J Immunol 2001;167:4609-4615.